Table 1 Clinical management and serum samples availability of 162 COVID-19 study patients.

From: Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

Clinical management

No. of patients

No. of patients with serum samples at visit performed

In-hospital

Outpatient clinic

Admitted to the Emergency Department

150 (92.6%)

  

 Discharged (not hospitalized)

16 (10.7%)

16

9

 Hospitalized

134 (89.3%)

  

   ≤7days

25 (18.7%)

25

19

   >7days

65 (48.5%)

65

44

   deceased

18 (13.4%)

18

na

   in need of ICU, recovered

15 (11.2%)

15

2

   in need of ICU, decease

11 (8.2%)

11

na

Admitted at the COVID-19 outpatient clinic

12 (7.4%)

  

 Not hospitalized

10

na

3

 Hospitalized

2

na

2

  1. ICU Intensive Care Unit, na not applicable
  2. A dedicated serum sample was collected during attendance at the hospital, which took place either at the Emergency Department or at the ward (called the in-hospital sample). Follow-up serum samples were collected at the COVID-19 outpatient clinic during the 1, 3 and 6 months visits after discharge
Back to article page